Searched for
COVID VACCINATION SAFETY
India's out-of-pocket healthcare spending drops significantly, govt data showsIndian families now pay less for healthcare. Out-of-pocket spending fell from 64.2% to 43.4% in ten years. This is due to the government sp...- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Trump admin confirms probe of possible Covid vaccine deathsSince Trump's appointment of Robert F. Kennedy Jr. as health secretary, the US government has initiated a major overhaul of vaccine policy,...
- Hassan heart attack death cases: India’s top drugmakers rally behind Covid vaccinesAmid over 20 sudden heart attack deaths in Karnataka’s Hassan district, leading drugmakers have defended Covid vaccines on social media. In...
- Heart-attack deaths: Biocon founder disapproves of CM Siddaramaiah doubting Covid vaccineBiocon founder Kiran Mazumdar-Shaw refuted Chief Minister Siddaramaiah's suggestion that Covid-19 vaccines might be linked to recent heart ...
- As COVID variant NB.1.8.1 spreads across the U.S., here's how much a booster vaccine will cost youA new COVID variant is spreading, but U.S. vaccine rules have changed. Healthy people under 65, pregnant women, and kids are no longer advi...
- Bharat Biotech says its Covaxin demonstrated ‘excellent safety records’Bharat Biotech has emphasized the safety of its Covaxin Covid vaccine, stating that it has shown excellent safety records with no vaccine-a...
- COVID-19 mRNA vaccines increase risk of cardiac-related death, says Florida Surgeon GeneralThe Florida Department of Health (Department) conducted an analysis through a self-controlled case series, which is a technique originally ...
- No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension"For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety...
- Emergency Use Listing nod to Covaxin expands availability of Covid vaccines: WHO officialCovaxin was also reviewed on October 5 by WHO's Strategic Advisory Group of Experts on Immunization (SAGE), which formulates vaccine specif...
- Recruitment of volunteers for trial of Covid vaccine Covovax on children beginsIndigenously developed Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator...
- Foreign nationals now eligible for Covid vaccination in India: GovtAccording to the statement, a significant number of foreign nationals are living in India, especially in large metropolitan areas. In these...
- Bharat Biotech claims 77.8% efficacy of Covaxin in phase-3 trialsAnnouncing the much awaited safety and efficacy data from phase-3 clinical trials of Covaxin, the IMCR director Prof Balram Bhargava said C...
- Coca Cola pledges Rs 50 crore towards facilitating vaccination, providing safety kits in IndiaThe initial contribution of Rs 50 crore is towards facilitating COVID vaccination, providing safety kits, creating awareness, and distribut...
- WHO gives nod to AstraZeneca vaccine and its 'tremendous potential'"The AstraZeneca COVID-19 vaccine (including Covishield) continues to have a positive benefit-risk profile, with tremendous potential to pr...
- Covid-19 vaccine safe, based on scientific evidence, AstraZeneca reassures the worldIt further said that, a review of available safety data of more than 17 million people vaccinated in the European Union (EU) and UK with it...
- Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effectivePfizer and German partner BioNTech SE are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus v...
- UNICEF to stockpile half a billion syringes by year-end to prepare for COVID-19 vaccinations“As the world awaits a COVID-19 vaccine, UNICEF has begun laying the groundwork for the rapid, safe and efficient delivery of the eventual ...
- To get approval in India, vaccines must work in at least 50% casesThe vaccine that will go for approval must elicit superior immune responses compared to no vaccination against Covid-19, the guidelines sai...
- Serum Institute of India to start phase II trials of Oxford vaccine this weekPhase I human trials were completed in the UK. In India, the volunteers will be administered two doses of the potential vaccine. Thereafter...
Load More
